Purpose: Understanding the causes of fertilization failure is an important research field in assisted reproductive
INTRODUCTION
Sperm dysfunction is one of the most common single causes of male infertility, yet remarkably our knowledge of the cellular and biochemical basis for this condition is very limited. Indeed, our understanding of the physiology of the normal human spermatozoon, let alone the dysfunctional spermatozoon, is elementary. The successful implementation of intracytoplasmic sperm injection (ICSI) has provided a unique means to allow couples diagnosed with severe male infertility to achieve their reproductive goal (1) . However, despite the great therapeutic advantages of the techniques, in vitro fertilization (IVF) and ICSI provides solutions to clinicians often in the absence of an etiologic or pathophysiologic diagnosis.
The underlying cause for their infertility are generally related to specific sperm defects that generally comprise low counts (Ͻ1 ϫ 10 6 /ml) and/or low motility (Ͻ30%) and/or severe teratozoospermic men (2) . Patients with these semen parameters are usually directly referred to the ICSI program. ICSI recently also has been applied to patients with obstructive azoospermia, since ICSI also is successfully applied using epididymal and testicular spermatozoa (3, 4) .
Current important issues being investigated among couples attending assisted reproductive programs include the determination of chromosomal abnormalities and sperm functional quality (5) . The need to employ a multidiagnostic approach during the clinical workup has been underlined by the participants of a Consensus Workshop in Advanced Andrology and it suggested that sperm functional assays should become part of the male diagnostic program (6) (7) (8) .
Sperm chromatin packaging as an indicator for fertilization in assisted reproduction recently has been underlined (9) (10) (11) . To evaluate the chromatin of mammalian sperm, numerous dyes and fluorochromes have been used, for example, aniline blue, methyl green, giemsa stain, ethidium bromide, acridine orange, and chromomycin A 3 (12, 13) . The binding capacity of these dyes is believed to reflect anomalies in the chromatin packing quality due the modifications of the nucleoprotein components occurring during spermiogenesis. Basically it involves replacement of histones by protamines and then further stabilization by the formation of intra-and intermolecular disulfide cross-links among the cysteine residues of the protamine molecule (13) .
The aim of this study was to evaluate the possible relationship between CMA 3 staining and (i) normal morphology and (ii) its ability to predict the functional integrity of spermatozoa in both IVF and ICSI treatment programs.
MATERIAL AND METHODS

Experimental Design
Based on semen parameters, 140 consecutive patients were directed to either the IVF or ICSI program. Patients with Ͻ4% normal forms, Ͻ1 ϫ 10 6 sperm/ml, and Յ40% motile cells (except for one patient with a motility of 50%) and a history of repeated failed IVF were admitted to the ICSI programme Patients in the IVF and ICSI program were classified according to CMA 3 staining. The criteria for CMA 3 classification were based on the results obtained during a previous study, where 44 .5%Ϯ13 was reported to be a cutoff value for CMA 3 staining among fertile and subfertile men (14) . This value was similar to that reported by others (11, 12) . In order to analyze the data of the present study; we calculated a second cutoff value estimated at 60.0% recorded as 1 SD above 44.5%. Accordingly, the data were stratified using three basic cutoff values for CMA 3 staining, namely Ͻ44%, Ͼ44-60%, and Ͼ60%. Data were analyzed according to CMA 3 staining values of 44.5% and 60% as cutoff values. Each CMA 3 category of patients were then further divided into two subgroups, namely Ͻ4% normal forms and Ն4% normal forms.
Ovulation Induction
Ovulation induction protocols were adapted to individual needs. A ''long'' and ''short'' protocol was the most commonly used. In the long protocol, Buserelin (Suprefact, Hoechst, IHD, Johannesburg, South Africa), Lucrin [gonadotropin-releasing hormone agonist (GnRHa), Abbott, IHD, Johannesburg, SA], and Gonal-F [recombinant follicle-stimulating hormone (FSH), Serono, Pty (Ltd), Johannesburg, SA) were used. The long protocol treatment was induced in the midluteal or late luteal phase and the short protocol administration of GnRHa begins in the early follicular phase. Both treatments continued until the day of human chorionic gonadotropin (hCG) (Profasi, Serono, Pty (Ltd), Johannesburg, SA) administration. FSH (Metrodin, Serono, Pty (Ltd), Johannesburg, SA) treatment was started after desensitization was achieved. The dose of FSH was tailored to the patient's response. When the largest follicle reached a diameter of 18 mm and the estradiol serum levels indicated a satisfactory follicular response, 10,000 IU hCG was administered.
In Vitro Fertilization
Metaphase II oocytes and embryos were cultured as suggested in the IVF Science and Medi-Cult literature (15) . Shortly, culture dishes (Falcon 1006, Becton Dickinson GmbH, Heidelberg) were prepared using 24-hr preequilibrated culture media (IVF-50; Scandinavian IVF Science products, Gothenburg, Sweden; Universal IVF medium; Medi-Cult, MØlleh-aven, Jyllinge) and Sigma mineral oil (Sigma-M-8410, embryo tested, Sigma-Aldrich, Johannesburg, SA). Three milliliters IVF-50 or Universal IVF medium was incubated in Falcon 2058 tubes (Becton Dickinson GmbH, Heidelberg) for the final swim-up or suspension of spermatozoa after employing a density gradient column separation. Spermatozoa were washed in ASP-100 (Scandinavian IVF Science prod-ucts, Gothenburg, Sweden) or flushing medium (Medi-Cult, Møllehaven, Jyllinge) and layered with 1.5 ml IVF-50 or Universal IVF. Insemination and oocyte culturing took place in IVF-50 or Universal IVF medium. On day 1, oocytes were denuded and fertilization assessed. Zygotes were transferred into six 50-Ȑl droplets IVF-50 (Scandinavian IVF Science products, Gothenburg, Sweden) or Universal IVF (Medi-Cult, Møllehaven, Jyllinge).
Two-to four-cell embryos were assessed on day 2 and transferred to prepared dishes, containing six 50-Ȑl droplets IVF-50 or Universal IVF medium. Culturing of day 3 embryos (8-10 cells) and embryo transfer took place in G2.2 (Scandinavian IVF Science products, Gothenburg, Sweden) or M3 Medium (MediCult, Møllehaven, Jyllinge).
The quality of the embryos were evaluated according to the following system, namely grades I, II, III, and IV. Grade I embryos were those embryos where the blastomeres were equal in size and with no fragments, whereas grade II embryos contained minor fragmentations, with equal-sized blastomeres. When fragments consisted of more than one third but less than two thirds of the volume of the embryo and/or blastomeres were of different sizes, the embryos were graded as grade III. Grade IV embryos showed a high degree of fragmentation (more than two thirds of the volume of the embryo) and blastomeres unequal in size.
Intracytoplasmic Sperm Injection
After retrieval the oocytes were incubated in 0.1% hyaluronidase for 1 to 2 min. The oocytes were rinsed (5 times) in fresh HEPES buffered medium. Prior to injection the oocytes (only metaphase II) were placed in 10 Ȑl HEPES buffered droplets under oil using 1006 Falcon Petri dish. A small volume (2-3 Ȑl) of prepared spermatozoa was deposited in a droplet of polyvinylpyrrolidone (PVP; Cat. No. 10890001. Medi-Cult, Harrilabs, Randburg, SA). Narishige micromanipulators mounted on a Nikon inverted microscope were used to perform the sperm injection. An individual morphologically normal sperm were immobilized and sucked into a Cook injection pipette (KMPIP-1035). The sperm were injected and the injected oocyte was then incubated according to the IVF protocol.
Semen Preparation
A total of 140 semen samples were obtained from men attending our fertility program. After complete liquefaction at room temperature, a basic semen analysis was performed according to the World Health Organization (2, 16). In short, recordings were made of the semen volume, concentration spermatozoa motility, and forward progression. Two separate slides were prepared to evaluate the percentage normal cells and the quality chromatin packaging.
For morphology evaluation all slides were stained with Papanicolaou stain, coverslipped, and then assessed for percentage normal cells according to strict criteria (2) . The quality chromatin packaging was determined using CMA 3 staining (Sigma Chemicals, St. Louis, MO, Cat. 2659) techniques (11, 12) . In short, CMA 3 staining thin smears were prepared, airdried, and fixed in methanol/acetic acid 3:1 at room temperature for 20 min. The slides were air-dried and stained with 60-100 Ȑl CMA 3 in a dark chamber for 20 min. Slides were then washed in McIlvaine buffer (17) and mounted using Dabco (Aldrich Chemicals Co., Milwaukee, WI, Cat. No. 29,073-4). Two hundred spermatozoa were evaluated under a Nikon fluorescent microscope (CFWN10X IMP, Johannesburg, SA; Filter Fx 465-495).
Statistical Analyses
The primary statistical methods employed in the studies included Spearman's rank order correlation between IVF and ICSI groups and semen parameters, logistic regression of fertilization defined as ''good'' or ''poor'' at some cutoff value (i.e., 60%) calculated by using fertilization rates from previous IVF cycles. In addition, predictive statistics, that is, sensitivity, specificity, and positive predictive value and negative predictive value for CMA 3 staining and IVF and ICSI results are reported. Predictive values were determined with a 2 ϫ 2 contingency table, while the statistical relevance was calculated with Yates corrected chi-square test. The discriminating power of sperm morphology and in vitro fertilization as a screening test for the identification of chromatin packaging was illustrated with receiver operating characteristics (18) .
RESULTS
Patients
Based on this CMA 3 classification, patients were divided into four groups, namely; group A, Ͻ44% Table I .
Sperm Morphology and Fertilization versus CMA 3 Staining
Evaluation of the 140 semen analyses revealed 39 cases diagnosed as normozoospermic (Ն14% normal forms), 61 cases as teratozoospermic (4-13% normal forms), and 39 cases as severe teratozoospermic (Ͻ4% normal forms). As expected, semen parameters were significantly poorer among the ICSI treated patients (group D), compared to that recorded of the IVF group (groups A, B, and C). The percentage of morphologically normal spermatozoa and the sperm count (ϫ10 6 /ml) were significantly different in the three IVF and ICSI groups. Percentage motility in the four groups did not differ significantly (Table I) . Although the highest fertilization rate (Table II) was found in group A (72.2%), it was not significantly higher than the fertilization rate in group B (64.0%). The fertilization rates reported for group C (43.7%) and group D (35.0%) were significantly lower compared to the fertilization rates in group A (72.2%) and group B (64.0%, P Ͻ 0.0001).
In the ICSI and IVF groups where CMA 3 staining values of Ͼ60% were reported the fertilization rates were 35.0% and 43.7%, respectively. This difference was not statistically significant. The cleavage rates as well as embryo quality in the four different groups were similar. Likewise, the number of embryos transferred per patient in the four different groups did not differ (Table II) . However the implantation and clinical pregnancy rates of the ICSI and IVF groups with a CMA 3 percentage of Ͼ60% were significantly lower (Table III) . No significant difference were observed in the implantation and clinical pregnancy rates in the IVF groups with a CMA 3 percentage of Ͻ44% and Ն44% to 60% (Table III) .
For IVF patients we used a fertilization rate cutoff value of 60% and a CMA 3 staining percentage of 44% and calculated the predictive values for CMA 3 as far as fertilization success is concerned. The positive predictive value was 80%, negative predictive value 49%, sensitivity 22%, and specificity of 93%. The low negative predictive value (NPV) (49%) and sensitivity (22%) implies that CMA 3 staining does not have a high discriminate level in predicting fertilization failure. The positive predictive value (PPV) of 80% and specificity of 93% indicates the power of CMA 3 staining to predict fertilization success. Possible explanation for the low sensitivity is possibly due to the large population of patients (n ϭ 39) that revealed slightly elevated CMA 3 (Ͼ44%-60%) values but succeeded in fertilizing Ͼ60% of the oocytes. Furthermore, using a CMA 3 cutoff value of 60% instead of the 44.5%, the 2 ϫ 2 contingency table revealed a sensitivity of 49%, specificity of 91%, PPV of 80%, and NPV of 60%.
Receiver Operator Characteristics Curve Analyses
The discriminating power of nuclear maturity, as recorded by CMA 3 staining, to identify abnormal morphology values and fertilization failure in the IVF groups were calculated with receiver operator characteristics (ROC) analyses. During ROC analyses we used 4% normal forms as a cutoff value to calculate the optimum sensitivity and specificity levels for CMA 3 staining. The areas under the curve were 0.89, sensitivity 75%, and specificity 100%. During these calculations, the indicated cutoff value for CMA 3 staining, to distinguish between Ͻ4% and Ն4% morphology groups, was 60% (Fig. 1) . When in vitro fertilization rates of Ͼ60% and Ͻ60% were used in the ROC analysis, the optimal CMA 3 value for accurate prediction of fertilization success was again recorded at 60%. The area under the curve was 0.76, sensitivity of 81.5%, and specificity of 63.6% (Fig. 2) . 
DISCUSSION
The development of a sequential analytical program in the diagnostic andrology laboratory, apart from sperm functional tests, should include assays that provide information that will assist clinicians on the therapeutic approach of couples attending an assisted reproductive program. During a Consensus Workshop in Advanced Andrology, four categories of tests were proposed as important sperm functional tests: (i) computer-assisted evaluation of sperm motion characteristics (CASA), (ii) inducibility of the acrosome reaction and bioassays that sequentially assess gamete interaction, including (iii) sperm-zona pellucida binding tests and (iv) sperm-hamster egg penetration assay (8) .
The ability of sperm to fertilize is not only closely correlated with the its morphology (2) but also to the quality of the chromatin packaging (10) (11) (12) . The constant remodeling of sperm chromatin that occurs during spermiogenesis and fertilization leads to special interest in the state of the DNA during the process. The changing structural state of sperm chromatin, as revealed by nucleases, and related alterations in methylation levels therefore are of particular interest during condensation and decondensation. These changes in chromatin are of particular interest be- be heritable through successive DNA replication cycles. These changes in chromatin are of particular interest because the modifications have been demonstrated to be heritable through successive DNA replication cycles (19) .
During fertilization, the decondensation process is characterized by the degradation of protamines, synthesis of histones, and binding of the histones to the DNA, leading to a restoration of the paternal genome and its transcriptionally active conformation. If an abnormal sperm containing underprotaminated chromatin and nicks in the DNA fertilizes an oocyte, then the fertilization process and ensuing development may not necessarily proceed normally. Investigation of chromatin state and methylation levels, especially during pronuclei formation, therefore may assist in the knowledge of the role played by the paternal component during embryogenesis. This is of interest, particularly as the paternal genome is earmarked for selective expression during early development (20) .
Present CMA 3 staining data indicate chromatin packaging quality to be a discriminator of in vitro fertilization success (Ͼ60% oocytes fertilized, a sensitivity of 81.5%, and specificity of 63.6% was recorded). The 95% confidence interval did not include 0.5 (0.70 to 0.83), meaning that CMA 3 staining could distinguish between IVF success and failure. An area under the curve of 0.76 means that a randomly selected individual with CMA 3 staining of Ͼ60% will fertilize Ͼ50% of metaphase II oocytes in 76% of the cases.
Furthermore, CMA 3 staining seems to be an excellent discriminator of sperm morphology, with a sensitivity of 75% and specificity of 100%. Again, the 95% confidence interval did not include 0.5 (0.81 to 0.90), meaning that CMA 3 staining could distinguish between Ͼ4% and Ͻ4% morphology samples. Groups A and B, that is, patients with Յ44% and Ն44%-60% CMA 3 , respectively, contained no severe teratozoospermic (Ͻ4% normal forms) patients, while 39 severe teratozoospermic men were classified in groups C and D, that is, men with Ͼ60% CMA 3 staining. It is important to note that each laboratory should determine its own cutoff value for CMA 3 staining. Results should be interpreted with caution, since the cutoff value of different institutions might be totally different. Its is therefore important to stratify the data from a large patient population in order to identify the gray areas of the test.
Previous reports have shown that a decrease in fertility is not only associated with sperm-displaying abnormal morphology but also revealed an increased sensitivity of the DNA to denaturation (21) . These observation have been confirmed (22, 23) whereby morphological abnormal sperm showed both a high level of fluorescence to CMA 3 fluorochrome and a high presence of endogenous nicks in the DNA. Even data including normal sperm morphology (Ͼ14%) have been correlated with fertility success; a normalshaped sperm head may contain chromosomes with microdeletions, aneuploidy, DNA strand breaks, and abnormal sperm chromatin structure and yet fertilize an oocyte. On the other hand, since ICSI overrides deficiencies in sperm motility, zona, and oolemma binding and leaves the successful completion of fertilization upon the sperm nucleus, we suggest that chromatin packaging assessments should be included as a complementary assay to the sequential diagnostic approach of the male factor patients (24) .
